Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe a..
Leer más
Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two rand..
Leer más
The pathobiology and treatment of mucus plugs in asthma and COPD: state of the artEosinófilos para acortar la corticoterapia en la exacerbación asmáticaUna estrategia prometedora pendiente de confirmaciónCambio a depemokimab cada seis meses en pacientes con asma grave previamente tratados con mepolizumab o benralizumabEarly Mepolizumab Plus Glucocorticoids in Newly Diagnosed Eosinophilic Granulomatosis With Polyangiitis: A 52-Week Multicenter Retrospective Cohort StudyAssociation between overuse of short-acting β2-agonists and the risk of major adverse cardiovascular events among patients with asthma